Table 1. Demographics and clinical characteristics of the study population.
ALL | NAFLD | No NAFLD | ||||
N,% or Median, SD | N,% or Median, SD | N,% or Median, SD | ||||
Age (median)(SD) | 57.9 | (15.3) | 59 | (13.6) | 56.3 | (17.5) |
Sex (males) | 293 | (41.8%) | 178 | (43.6%) | 115 | (39.4%) |
(females) | 307 | (58.2%) | 230 | (56.4%) | 177 | (60.8%) |
Race | ||||||
Caucasian | 534 | (76.4%) | 318 | (80%) | 216 | (74.2%) |
African American | 98 | (14%) | 45 | (11%) | 53 | (18.3%) |
Hispanic | 17 | (0.02%) | 16 | (3.9%) | 1 | (0.3%) |
Other | 50 | (0.07%) | 29 | (7.1%) | 21 | (7.2%) |
Smokers | 237 | (33.8%) | 142 | (34.8%) | 96 | (32.9%) |
Illicit Drug Users | 73 | (10.4%) | 46 | (11.3%) | 27 | (9.3%) |
Hypertensive | 421 | (60.1%) | 262 | (64.2%) | 159 | (54.5%) |
CAD | 94 | (13.4%) | 45 | (11.0%) | 49 | (16.8%) |
Hyperlipidemia | 230 | (32.8%) | 123 | (30.2%) | 107 | (36.6%) |
Diabetics | 224 | (32%) | 156 | (38.2%) | 68 | (23.3%) |
Obese | 339 | (48.4%) | 214 | (52.5%) | 125 | (42.8%) |
CHF | 38 | (0.05%) | 23 | (5.6%) | 15 | (5.1%) |